Effect of early dose increase of evocalcet for intractable hypercalcemia caused by parathyroid carcinoma
Hypercalcemia due to parathyroid carcinoma (PC) is safely and quickly controlled with rapidly increasing evocalcet doses. Most parathyroid carcinomas are detected because of hypercalcemia due to primary hyperparathyroidism (PHPT). Hypercalcemia becomes more severe in patients with PC than those with...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2023-01-01
|
| Series: | European Thyroid Journal |
| Online Access: | https://edm.bioscientifica.com/view/journals/edm/2023/1/EDM22-0269.xml |